KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS

Clinical trials for KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS trials appear

Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Safer shield? study tests gentler drug to protect transplant patients from viruses

Disease control Recruiting now

This study aims to find out if a drug called valacyclovir works as well as the standard drug, valganciclovir, at preventing dangerous viral infections in people who have received a kidney transplant. Researchers want to see if valacyclovir causes fewer serious side effects, like …

Matched conditions: KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS

Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS

Get alerted when new KIDNEY TRANSPLANTATION, CYTOMEGALOVIRUS INFECTIONS trials appear

Safer shield? study tests gentler drug to protect transplant patients from viruses